Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02960789 · ClinicalTrials.gov registry record · NA
Hydration Status Evaluation of Dehydrated Children With Experimental Devices
A NA study, sponsored by Massachusetts Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT02960789: Completed NA study, sponsored by Massachusetts Institute of Technology.
NCT02960789 is a NA study that has completed, run by Massachusetts Institute of Technology. The registered enrollment target is 137 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02960789, a NA study, has completed, sponsored by Massachusetts Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
A pediatric study in collaboration with Boston Children's Hospital to review the performance of two novel hydration status measurement devices against standard clinical assessment methods, through repeated measurement of hydration status of dehydrated children admitted to the emergency department receiving rehydration therapy, followed by an at-home follow-up measurement once symptoms have resolved.
Interventions
- OTHER Formalized clinical assessment of hydration status
- OTHER Take a measurement of body weight on calibrated scales
- DEVICE "RF wristband" hydration status measurement
- OTHER Measure capillary refill time with manual stopwatch
- DEVICE "CRT device" hydration status measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-04 |
| Phase | NA |
What the finished NCT02960789 record still lists
NCT02960789 is an interventional study that assigns participants to a tested intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 5 interventions - of which Formalized clinical assessment of hydration status is the first listed.
NCT02960789 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02960789 about?
NCT02960789 is a clinical study titled "Hydration Status Evaluation of Dehydrated Children With Experimental Devices". A pediatric study in collaboration with Boston Children's Hospital to review the performance of two novel hydration status measurement devices against standard clinical assessment methods, through repeated measurement of hydration status of dehydrated children admitted to the emergency department re...
What is the current status of trial NCT02960789?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2016-11. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02960789?
The interventions under investigation include: Formalized clinical assessment of hydration status (OTHER), Take a measurement of body weight on calibrated scales (OTHER), "RF wristband" hydration status measurement (DEVICE), Measure capillary refill time with manual stopwatch (OTHER), "CRT device" hydration status measurement (DEVICE).
Who is sponsoring clinical trial NCT02960789?
This trial is sponsored by Massachusetts Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02960789's enrollment target sits among peer trials
137 722nd of 2000 higher than 1,279 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05091424 · 137 participants · Phase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- NCT05655182 · 137 participants · Phase 1
A Study of BLB-201 RSV Vaccine in Infants and Children
- NCT06571669 · 137 participants · NA
BOOM-IBD2 Pivotal Clinical Trial
- NCT06644768 · 137 participants · Phase 1
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia